Placebo controlled trial showed that memantine improves social impairment in youths, suggesting it is a viable intervention.
Twelve weeks of treatment with memantine resulted in significant improvement in social impairment among youths with autism spectrum disorder, a placebo‐controlled trial has found. Memantine also did not result in significantly more adverse events compared with placebo. Study results were published online Oct. 1, 2025, in JAMA Network Open .
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: